CD279, Human (Pidilizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-CD279, Human (Pidilizumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD279, Human (Pidilizumab biosimilar) |
| Clone | Pidilizumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG1 kappa |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human CD279 Recombinant Antibody (Pidilizumab). Pidilizumab (formerly CT-011) is a monoclonal antibody being developed by Medivation for the treatment of cancer and infectious diseases. Pidilizumab was originally thought to bind to the PD-1 immune checkpoint molecule, however, recent evidence suggests that Delta-like 1 (DLL1) is its primary binding target while binding to PD-1 is secondary and restricted to non-glycosylated and hypoglycosylated forms of this molecule. |
| Immunogen | n/a |
| Other Names | Anti-CD279 Recombinant Antibody, Research Grade Pidilizumab, Anti-Human CD279 Recombinant Antibody(Pidilizumab), CT-011, Antibody Drug Analogues, Monoclonal Antibody, YR1298, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 1036730-42-3 |
| Catalog # | YR1298 |
| Price | please inquire |
| Order / More Info | CD279, Human (Pidilizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies